You are here

Relyvrio

Amylyx Rebuilds Momentum Following Relyvrio Market Withdrawal

BioSpace

Wed, 07/24/24 - 11:33 am

Amylyx to rebuild pipeline with $35m Phase III ready GLP-1RA acquisition

Clinical Trials Arena

Wed, 07/10/24 - 11:18 am

clinical trials

Eiger BioPharmaceuticals

Amylyx at a Crossroads: Can the Company Overcome the Loss of Relyvrio?

BioSpace

Wed, 04/17/24 - 11:22 am

Amylyx to pull ALS drug Relyvrio From US, Canada markets after phase III fail

BioSpace

Thu, 04/4/24 - 11:25 am

Amylyx Pharmaceuticals

Setbacks reset views on highly touted Alzheimer's and ALS drugs

Axios

Mon, 03/11/24 - 05:06 pm

Alzheimer's disease

After trial failure, will Amylyx pull ALS drug Relyvrio off the market?

Fierce Pharma

Fri, 03/8/24 - 11:33 am

Amylyx’s ALS drug could face rejection in Europe

BioPharma Dive

Wed, 05/31/23 - 10:45 am

Amylyx’s ALS drug Relyvrio generates $71.4M in Q1

Medical Marketing and Media

Mon, 05/15/23 - 10:14 am

Amylyx Pharmaceuticals

Amylyx’s ALS drug sales impress Wall Street

BioPharma Dive

Tue, 03/14/23 - 11:28 am

Amylyx counters Wall Street noise, cites demand for ALS drug

Medical Marketing and Media

Wed, 02/15/23 - 10:39 am

Amylyx Pharmaceuticals

Cigna restricts coverage of new ALS drug, deepening fears about access

BioPharma Dive

Wed, 02/8/23 - 10:48 am

Amylyx Pharmaceuticals

For ALS patients, doctors, a new medicine reignites concerns about healthcare access

BioPharma Dive

Thu, 12/15/22 - 10:58 am

Days after Relyvrio’s FDA approval, Amylyx announces public offering to fund effort

Medical Marketing and Media

Wed, 10/5/22 - 07:13 pm

Amylyx Pharmaceuticals

ALS drug's approval draws cheers from patients, questions from skeptics

NPR

Sun, 10/2/22 - 07:45 pm

Amylyx Pharmaceuticals

FDA approves ALS drug from Amylyx, giving patients a much-needed treatment option

Stat

Thu, 09/29/22 - 07:44 pm

Amylyx Pharmaceuticals